Key Market Indicator:
Stock market news: In short news style a la Twitter/X. Everything that is relevant - at a glance. The entry page for the informed investor. Compact, worth knowing and always up to date. Directly from the IR departments of the companies.
CH0009115129
Fri, 26.04.2024
Kinarus Therapeutics Holding AG
Ad hoc announcement pursuant to Art. 53 LR
The Business Combination of Kinarus Therapeutics Holding AG (now renamed to Curatis Holding AG) with Curatis AG and related transactions were completed on 25 April 2024
The first trading day of the combined entities, Curatis Group (CURN.SW), is today, 26 April 2024
A total of CHF4.36m in cash was rais [ … ]
Wed, 17.04.2024
Kinarus Therapeutics Holding AG
Ad hoc announcement pursuant to Art. 53 LR
Publication of audited Consolidated & Statutory FY2023 Financial Statements of Kinarus Therapeutics Holding AG
Announcement of the postponement of the publication of the Annual Report 2023
Announcement of details and timeline of the contemplated Reverse Share Split
Announcement of final timeline for [ … ]
Fri, 01.03.2024
Kinarus Therapeutics Holding AG
Kinarus Therapeutics Holding AG
/ Key word(s): AGMEGM
Extraordinary General Meeting of Kinarus Holding approved all resolutions relating to the envisaged Business Combination with Curatis
01.03.2024 / 18:36 CET/CEST
MEDIA RELEASE
Basel, Switzerland, 1 March 2024: Kinarus Therapeutics Holding AG (SIX:KNRS) (“Kinarus Hol [ … ]
Wed, 28.02.2024
Kinarus Therapeutics Holding AG
Ad hoc announcement pursuant to Art. 53 LR
These financial statements published today are unaudited and may be subject to change.
Reader of these financial statements shall not place undue reliance on it. Any decision should be made solely on the basis of the audited financial statements which will supersede these financial statements in its entir [ … ]
Tue, 06.02.2024
Kinarus Therapeutics Holding AG
Ad hoc announcement pursuant to Art. 53 LR
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES OF AMERICA, ITALY, CANADA, SOUTH AFRICA, JAPAN OR AUSTRALIA OR ANY OTHER JURISDICTION IN WHICH THE DISTRIBUTION OR RELEASE WOULD BE UNLAWFUL OR REQUIRE REGISTRATION OR ANY OTHER MEASURES. [ … ]
Mon, 29.01.2024
Kinarus Therapeutics Holding AG
Ad hoc announcement pursuant to Art. 53 LR
Application has been made to the courts of Basel-Stadt to reverse the bankruptcy of Kinarus Therapeutics Holding AG in Liquidation (“Kinarus Holding”) (approval pending) in order to pursue a Combination Transaction with Curatis AG (“Curatis”)
Curatis valued at approx. 14x the value of Kinarus Holding in t [ … ]